skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 402  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: Journal Title: The American Journal Of Cardiology remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy
Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy
Material Type:
Article 		Add to My Research

Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy

The American journal of cardiology, 2016-06, Vol.117 (12), p.1928-1933 [Peer Reviewed Journal]

The Authors ;2016 The Authors ;Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jun 15, 2016 ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2016.03.043 ;PMID: 27138185 ;CODEN: AJCDAG

Full text available

Citations Cited by
2
Effects of RG7652, a Monoclonal Antibody Against PCSK9, on LDL-C, LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or With Established Coronary Heart Disease (from the Phase 2 EQUATOR Study)
Effects of RG7652, a Monoclonal Antibody Against PCSK9, on LDL-C, LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or With Established Coronary Heart Disease (from the Phase 2 EQUATOR Study)
Material Type:
Article 		Add to My Research

Effects of RG7652, a Monoclonal Antibody Against PCSK9, on LDL-C, LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or With Established Coronary Heart Disease (from the Phase 2 EQUATOR Study)

The American journal of cardiology, 2017-05, Vol.119 (10), p.1576-1583 [Peer Reviewed Journal]

2017 Elsevier Inc. ;Copyright © 2017 Elsevier Inc. All rights reserved. ;Copyright Elsevier Sequoia S.A. May 15, 2017 ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2017.02.020 ;PMID: 28343601

Full text available

Citations Cited by
3
Meta-Analysis of Comparison of Effectiveness of Lowering Apolipoprotein B Versus Low-Density Lipoprotein Cholesterol and Nonhigh-Density Lipoprotein Cholesterol for Cardiovascular Risk Reduction in Randomized Trials
Meta-Analysis of Comparison of Effectiveness of Lowering Apolipoprotein B Versus Low-Density Lipoprotein Cholesterol and Nonhigh-Density Lipoprotein Cholesterol for Cardiovascular Risk Reduction in Randomized Trials
Material Type:
Article 		Add to My Research

Meta-Analysis of Comparison of Effectiveness of Lowering Apolipoprotein B Versus Low-Density Lipoprotein Cholesterol and Nonhigh-Density Lipoprotein Cholesterol for Cardiovascular Risk Reduction in Randomized Trials

The American journal of cardiology, 2012-11, Vol.110 (10), p.1468-1476 [Peer Reviewed Journal]

Elsevier Inc. ;2012 Elsevier Inc. ;2014 INIST-CNRS ;Copyright © 2012 Elsevier Inc. All rights reserved. ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2012.07.007 ;PMID: 22906895 ;CODEN: AJCDAG

Full text available

Citations Cited by
4
Efficacy and Safety of Alirocumab Versus Ezetimibe Over 2 Years (from ODYSSEY COMBO II)
Efficacy and Safety of Alirocumab Versus Ezetimibe Over 2 Years (from ODYSSEY COMBO II)
Material Type:
Article 		Add to My Research

Efficacy and Safety of Alirocumab Versus Ezetimibe Over 2 Years (from ODYSSEY COMBO II)

The American journal of cardiology, 2017-09, Vol.120 (6), p.931-939 [Peer Reviewed Journal]

2017 The Authors ;Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Sep 15, 2017 ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2017.06.023 ;PMID: 28750828

Full text available

Citations Cited by
5
Effects of Atorvastatin (80 mg) Therapy on Quantity of Epicardial Adipose Tissue in Patients Undergoing Pulmonary Vein Isolation for Atrial Fibrillation
Effects of Atorvastatin (80 mg) Therapy on Quantity of Epicardial Adipose Tissue in Patients Undergoing Pulmonary Vein Isolation for Atrial Fibrillation
Material Type:
Article 		Add to My Research

Effects of Atorvastatin (80 mg) Therapy on Quantity of Epicardial Adipose Tissue in Patients Undergoing Pulmonary Vein Isolation for Atrial Fibrillation

The American journal of cardiology, 2015-11, Vol.116 (9), p.1443-1446 [Peer Reviewed Journal]

Elsevier Inc. ;2015 Elsevier Inc. ;Copyright © 2015 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Nov 1, 2015 ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2015.07.067 ;PMID: 26372211 ;CODEN: AJCDAG

Full text available

Citations Cited by
6
Results of Bococizumab, A Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, from a Randomized, Placebo-Controlled, Dose-Ranging Study in Statin-Treated Subjects With Hypercholesterolemia
Results of Bococizumab, A Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, from a Randomized, Placebo-Controlled, Dose-Ranging Study in Statin-Treated Subjects With Hypercholesterolemia
Material Type:
Article 		Add to My Research

Results of Bococizumab, A Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, from a Randomized, Placebo-Controlled, Dose-Ranging Study in Statin-Treated Subjects With Hypercholesterolemia

The American journal of cardiology, 2015-05, Vol.115 (9), p.1212-1221 [Peer Reviewed Journal]

The Authors ;2015 The Authors ;Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited May 1, 2015 ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2015.02.006 ;PMID: 25784512 ;CODEN: AJCDAG

Full text available

Citations Cited by
7
Aggressive Low-Density Lipoprotein Cholesterol Lowering Soon After Acute Coronary Syndrome: Should We Hit Early and Hit Hard?
Aggressive Low-Density Lipoprotein Cholesterol Lowering Soon After Acute Coronary Syndrome: Should We Hit Early and Hit Hard?
Material Type:
Article 		Add to My Research

Aggressive Low-Density Lipoprotein Cholesterol Lowering Soon After Acute Coronary Syndrome: Should We Hit Early and Hit Hard?

The American journal of cardiology, 2024-03, Vol.214, p.180-181 [Peer Reviewed Journal]

2023 Elsevier Inc. ;2023. Elsevier Inc. ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2023.12.035 ;PMID: 38160926

Full text available

Citations Cited by
8
Lipid Profile and Subsequent Cardiovascular Disease among Young Adults Aged < 50 Years
Lipid Profile and Subsequent Cardiovascular Disease among Young Adults Aged < 50 Years
Material Type:
Article 		Add to My Research

Lipid Profile and Subsequent Cardiovascular Disease among Young Adults Aged < 50 Years

The American journal of cardiology, 2021-03, Vol.142, p.59-65 [Peer Reviewed Journal]

2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2020.11.038 ;PMID: 33301771

Full text available

Citations Cited by
9
Very High High-Density Lipoprotein Cholesterol Levels and Cardiovascular Mortality
Very High High-Density Lipoprotein Cholesterol Levels and Cardiovascular Mortality
Material Type:
Article 		Add to My Research

Very High High-Density Lipoprotein Cholesterol Levels and Cardiovascular Mortality

The American journal of cardiology, 2022-03, Vol.167, p.43-53 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021. Elsevier Inc. ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2021.11.041 ;PMID: 35039162

Full text available

Citations Cited by
10
Relationship Between Serum Low-Density Lipoprotein Cholesterol and In-hospital Mortality Following Acute Myocardial Infarction (The Lipid Paradox)
Relationship Between Serum Low-Density Lipoprotein Cholesterol and In-hospital Mortality Following Acute Myocardial Infarction (The Lipid Paradox)
Material Type:
Article 		Add to My Research

Relationship Between Serum Low-Density Lipoprotein Cholesterol and In-hospital Mortality Following Acute Myocardial Infarction (The Lipid Paradox)

The American journal of cardiology, 2015-03, Vol.115 (5), p.557-562 [Peer Reviewed Journal]

Elsevier Inc. ;2015 Elsevier Inc. ;Copyright © 2015 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Mar 1, 2015 ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2014.12.006 ;PMID: 25727079 ;CODEN: AJCDAG

Full text available

Citations Cited by
11
Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)
Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)
Material Type:
Article 		Add to My Research

Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)

The American journal of cardiology, 2015-12, Vol.116 (12), p.1840-1844 [Peer Reviewed Journal]

Elsevier Inc. ;2015 Elsevier Inc. ;Copyright © 2015 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Dec 15, 2015 ;ISSN: 0002-9149 ;ISSN: 1879-1913 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2015.09.026 ;PMID: 26602073 ;CODEN: AJCDAG

Full text available

Citations Cited by
12
The Trajectory of Lipoprotein(a) During the Peri- and Early Postinfarction Period and the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition
The Trajectory of Lipoprotein(a) During the Peri- and Early Postinfarction Period and the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition
Material Type:
Article 		Add to My Research

The Trajectory of Lipoprotein(a) During the Peri- and Early Postinfarction Period and the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition

The American journal of cardiology, 2022-05, Vol.171, p.1-6 [Peer Reviewed Journal]

2022 Elsevier Inc. ;Copyright © 2022 Elsevier Inc. All rights reserved. ;2022. Elsevier Inc. ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2022.01.058 ;PMID: 35314069

Full text available

Citations Cited by
13
Efficacy, Safety, Tolerability, and Pharmacokinetic Profile of Evacetrapib Administered as Monotherapy or in Combination With Atorvastatin in Japanese Patients With Dyslipidemia
Efficacy, Safety, Tolerability, and Pharmacokinetic Profile of Evacetrapib Administered as Monotherapy or in Combination With Atorvastatin in Japanese Patients With Dyslipidemia
Material Type:
Article 		Add to My Research

Efficacy, Safety, Tolerability, and Pharmacokinetic Profile of Evacetrapib Administered as Monotherapy or in Combination With Atorvastatin in Japanese Patients With Dyslipidemia

The American journal of cardiology, 2014-06, Vol.113 (12), p.2021-2029 [Peer Reviewed Journal]

The Authors ;2014 The Authors ;Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved. ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2014.03.045 ;PMID: 24786356

Full text available

Citations Cited by
14
Influence of the Type of Disability and Sporting Discipline on Lipid Profile in a Cohort of Italian Paralympic Athletes
Influence of the Type of Disability and Sporting Discipline on Lipid Profile in a Cohort of Italian Paralympic Athletes
Material Type:
Article 		Add to My Research

Influence of the Type of Disability and Sporting Discipline on Lipid Profile in a Cohort of Italian Paralympic Athletes

The American journal of cardiology, 2024-01, Vol.210, p.107-112 [Peer Reviewed Journal]

Copyright © 2023 Elsevier Inc. All rights reserved. ;2023. Elsevier Inc. ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2023.09.118 ;PMID: 38682709

Full text available

Citations Cited by
15
Early Initiation of PCSK9 Inhibitor Therapy versus Placebo in Patients with Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
Early Initiation of PCSK9 Inhibitor Therapy versus Placebo in Patients with Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
Material Type:
Article 		Add to My Research

Early Initiation of PCSK9 Inhibitor Therapy versus Placebo in Patients with Acute Coronary Syndrome: A Systematic Review and Meta-Analysis

The American journal of cardiology, 2024-02, Vol.213, p.110-118 [Peer Reviewed Journal]

2023 ;Copyright © 2023 Elsevier Inc. All rights reserved. ;2023. Elsevier Inc. ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2023.10.043 ;PMID: 37875235

Full text available

Citations Cited by
16
Impact of Guideline-Directed Management Strategies for Low-Density Lipoprotein Cholesterol Control in Patients Who Underwent Percutaneous Coronary Intervention
Impact of Guideline-Directed Management Strategies for Low-Density Lipoprotein Cholesterol Control in Patients Who Underwent Percutaneous Coronary Intervention
Material Type:
Article 		Add to My Research

Impact of Guideline-Directed Management Strategies for Low-Density Lipoprotein Cholesterol Control in Patients Who Underwent Percutaneous Coronary Intervention

The American journal of cardiology, 2024-02, Vol.213, p.20-27 [Peer Reviewed Journal]

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved. ;2023. The Author(s) ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2023.11.067 ;PMID: 38103764

Full text available

Citations Cited by
17
A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With Hypertriglyceridemia
A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With Hypertriglyceridemia
Material Type:
Article 		Add to My Research

A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With Hypertriglyceridemia

The American journal of cardiology, 2016-05, Vol.117 (9), p.1444-1448 [Peer Reviewed Journal]

Elsevier Inc. ;2016 Elsevier Inc. ;Copyright © 2016 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited May 1, 2016 ;ISSN: 0002-9149 ;ISSN: 1879-1913 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2016.02.011 ;PMID: 26969416 ;CODEN: AJCDAG

Full text available

Citations Cited by
18
Statin Therapy in Patients With Low Serum Levels of Low-Density Lipoprotein Cholesterol
Statin Therapy in Patients With Low Serum Levels of Low-Density Lipoprotein Cholesterol
Material Type:
Article 		Add to My Research

Statin Therapy in Patients With Low Serum Levels of Low-Density Lipoprotein Cholesterol

The American journal of cardiology, 2017-12, Vol.120 (11), p.1947-1954 [Peer Reviewed Journal]

2017 Elsevier Inc. ;Copyright © 2017 Elsevier Inc. All rights reserved. ;Copyright Elsevier Sequoia S.A. Dec 1, 2017 ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2017.08.011 ;PMID: 28951019

Full text available

Citations Cited by
19
Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Atherogenic Lipid/Lipoprotein, Apolipoprotein, and Inflammatory Parameters in Patients With Elevated High-Sensitivity C-Reactive Protein (from the ANCHOR Study)
Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Atherogenic Lipid/Lipoprotein, Apolipoprotein, and Inflammatory Parameters in Patients With Elevated High-Sensitivity C-Reactive Protein (from the ANCHOR Study)
Material Type:
Article 		Add to My Research

Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Atherogenic Lipid/Lipoprotein, Apolipoprotein, and Inflammatory Parameters in Patients With Elevated High-Sensitivity C-Reactive Protein (from the ANCHOR Study)

The American journal of cardiology, 2019-09, Vol.124 (5), p.696-701 [Peer Reviewed Journal]

2019 The Authors ;Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. ;2019. The Authors ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2019.05.057 ;PMID: 31277790

Full text available

Citations Cited by
20
Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL Trial
Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL Trial
Material Type:
Article 		Add to My Research

Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL Trial

The American journal of cardiology, 2017-02, Vol.119 (3), p.379-387 [Peer Reviewed Journal]

2016 Elsevier Inc. ;Copyright © 2016 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Feb 1, 2017 ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2016.10.037 ;PMID: 27939230 ;CODEN: AJCDAG

Full text available

Citations Cited by

Results 1 - 20 of 402  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 1988  (26)
  2. 1988 To 1993  (49)
  3. 1994 To 1999  (156)
  4. 2000 To 2016  (120)
  5. After 2016  (52)
  6. More options open sub menu

Databases 

  1. MEDLINE  (402)
  2. ProQuest Central  (393)
  3. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait